| Title |
The cost-utility of aflibercept for the treatment of age-related macular degeneration compared to bevacizumab and ranibizumab and the influence of model parameters
|
|---|---|
| Published in |
Graefe's Archive for Clinical and Experimental Ophthalmology, April 2014
|
| DOI | 10.1007/s00417-014-2641-3 |
| Pubmed ID | |
| Authors |
Mari Elshout, Margriet I. van der Reis, Carroll A. B. Webers, Jan S. A. G. Schouten |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 90 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 2% |
| Spain | 1 | 1% |
| Unknown | 87 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 15 | 17% |
| Researcher | 13 | 14% |
| Student > Ph. D. Student | 12 | 13% |
| Student > Bachelor | 12 | 13% |
| Student > Doctoral Student | 7 | 8% |
| Other | 12 | 13% |
| Unknown | 19 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 26 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 10 | 11% |
| Nursing and Health Professions | 8 | 9% |
| Biochemistry, Genetics and Molecular Biology | 5 | 6% |
| Agricultural and Biological Sciences | 5 | 6% |
| Other | 11 | 12% |
| Unknown | 25 | 28% |